MSMichael A. Steinman

Michael A. Steinman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael A. Steinman has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • C. Seth Landefeld

    From San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California; and Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

    2 shared publications
  • Michael G. Shlipak

    2 shared publications
  • Ralph Gonzales

    From San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California; and Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

    2 shared publications
  • Brian B. Hoffman

    1 shared publication
  • Eugene Z. Oddone

    1 shared publication
  • Hayden B. Bosworth

    1 shared publication

Latest Publications

  • Clinician awareness of adherence to hypertension guidelines

    by Michael A. Steinman, Melissa A. Fischer, Michael G. Shlipak, Hayden B. Bosworth, Eugene Z. Oddone, Brian B. Hoffman, Mary K. Goldstein


  • Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999

    by Michael A. Steinman, Ralph Gonzales, Jeffrey A. Linder, C. Seth Landefeld

    Judicious use of antibiotics can slow the spread of antimicrobial resistance. However, overall patterns of antibiotic use among ambulatory patients are not well understood. To study patterns of outpatient antibiotic use in the United States, focusing on broad-spectrum antibiotics. Cross-sectional survey in three 2-year periods (19911992, 19941995, and 19981999). The National Ambulatory Medical Care Survey, a nationally representative sample of community-based outpatient visits. Patients visiting community-based outpatient clinics. Rates of overall antibiotic use and use of broad-spectrum antibiotics (azithromycin and clarithromycin, quinolones, amoxicillinclavulanate, and second- and third-generation cephalosporins). All comparisons were made between the first study period (19911992) and the final study period (19981999). Between 19911992 and 19981999, antibiotics were used less frequently to treat acute respiratory tract infections, such as the common cold and pharyngitis. However, use of broad-spectrum agents increased from 24% to 48% of antibiotic prescriptions in adults (P < 0.001) and from 23% to 40% in children (P < 0.001). Use of broad-spectrum antibiotics increased across many conditions, increasing two- to threefold as a percentage of total antibiotic use for a variety of diagnoses in both adults and children. By 19981999, 22% of adult and 14% of pediatric prescriptions for broad-spectrum antibiotics were for the common cold, unspecified upper respiratory tract infections, and acute bronchitis, conditions that are primarily viral. Antibiotic use in ambulatory patients is decreasing in the United States. However, physicians are increasingly turning to expensive, broad-spectrum agents, even when there is little clinical rationale for their use.


  • Open Access

    Predictors of Broad-Spectrum Antibiotic Prescribing for Acute Respiratory Tract Infections in Adult Primary Care

    by Michael A. Steinman, C. Seth Landefeld, Ralph Gonzales

    Antibiotics are commonly prescribed for acute respiratory tract infections (ARTIs).1-4 Some of this use, such as for the common cold and uncomplicated acute bronchitis, is almost always unnecessary.5,6 For other infections, such as otitis media and acute sinusitis, antibiotics provide some benefit, but the value of their use as first-line treatment has been debated.6,7


  • Self-restriction of medications due to cost in seniors without prescription coverage.

    by M A Steinman, L P Sands, K E Covinsky

    Little is known about patients who skip doses or otherwise avoid using their medications because of cost. We sought to identify which elderly patients are at highest risk of restricting their medications because of cost, and how prescription coverage modifies this risk. Cross-sectional study from the 1995-1996 wave of the Survey of Asset and Health Dynamics Among the Oldest Old, a population-based survey of Americans age 70 years and older. Subjects were asked the extent of their prescription coverage, and whether they had taken less medicine than prescribed for them because of cost over the prior 2 years. We used bivariate and multivariate analyses to identify risk factors for medication restriction in subjects who lacked prescription coverage. Among these high-risk groups, we then examined the effect of prescription coverage on rates of medication restriction. Of 4,896 seniors who regularly used prescription medications, medication restriction because of cost was reported by 8% of subjects with no prescription coverage, 3% with partial coverage, and 2% with full coverage (P <.01 for trend). Among subjects with no prescription coverage, the strongest independent predictors of medication restriction were minority ethnicity (odds ratio [OR], 2.9 compared with white ethnicity; 95% confidence interval [95% CI], 2.0 to 4.2), annual income <$10,000 (OR, 3.8 compared with income > or =$20,000; 95% CI, 2.4 to 6.1), and out-of-pocket prescription drug costs >$100 per month (OR, 3.3 compared to costs < or =$20; 95% CI, 1.5 to 7.2). The prevalence of medication restriction in members of these 3 risk groups was 21%, 16%, and 13%, respectively. Almost half (43%) of subjects with all 3 risk factors and no prescription coverage reported restricting their use of medications. After multivariable adjustment, high-risk subjects with no coverage had 3 to 15 times higher odds of medication restriction than subjects with partial or full coverage (P <.01). Medication restriction is common in seniors who lack prescription coverage, particularly among certain vulnerable groups. Seniors in these high-risk groups who have prescription coverage are much less likely to restrict their use of medications.